CALLAHAN EYE FOUNDATION HOSP — History
CCN 010018 | 3-year financial timeline | COVID resilience: 71/100
🛡️ Public data only — no PHI permitted on this instance.
$92M
Latest Revenue (FY2022)
+12.7%
Revenue CAGR (3yr)
0.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $73M | $85M | $92M | +8.6% | +12.7% |
| Operating Expenses | $74M | $84M | $92M | +9.3% | +11.1% |
| Operating Margin | -2.0% | 1.4% | 0.8% | -43.3% | +0.0% |
| Net Income | $-1M | $1M | $1M | -38.4% | +0.0% |
| Licensed Beds | 6 | 6 | 6 | +0.0% | +0.0% |
| Total Patient Days | 398 | 345 | 363 | +5.2% | -4.5% |
| Medicare Day % | 28% | 28% | 20% | -30.2% | -16.0% |
| Medicaid Day % | 7% | 7% | 5% | -29.8% | -15.3% |
COVID Impact & Recovery
Resilience Score: 71/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +27.0% ($73M → $92M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+12.7%
This Hospital
+7.6%
State Avg
Latest Margin
0.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $102M | 2.2% |
| FY2024 (proj) | $112M | 3.6% |
| FY2025 (proj) | $122M | 5.0% |